17 research outputs found

    Individual patient data meta‐analysis of patients treated with a heparin‐bonded Viabahn in the femoropopliteal artery for chronic limb‐threatening ischemia

    Get PDF
    ObjectivesThe aim of the study was to analyze available data on patients treated for chronic limb-threatening ischemia (CLTI) with the heparin-bonded Viabahn endoprosthesis.BackgroundThe patency of self-expanding covered stents in patients with complex femoropopliteal lesions is encouraging. However, data were mostly derived in patients with intermittent claudication. Patients with CLTI often have more advanced disease and worse outcome.MethodsAfter the abstract screening, full-text papers were checked. Authors were approached to consider joining the consortium. Data were sent anonymously, databases were merged and an individual patient data meta-analysis was performed. Kaplan–Meier curves were used to calculate the freedom from amputations, the amputation-free survival, and patency rates.ResultsSeven studies were enrolled, representing 161 limbs that were treated for CLTI. Median lesion length was 28.0 cm (interquartile range 25.0–33.0 cm) and 82.7% were chronic total occlusions. The technical success rate was 98.1% and the 30-day mortality 1.9%. Through 2-year follow-up, the freedom-from-major-amputations was 99.3%, with an amputation-free survival of 78.8%. The freedom-from-loss-of primary, primary-assisted, and secondary patency was 70.4%, 71.8%, and 88.2%, respectively, at 1-year and 59.5%, 62.7%, and 86.1% at 2-year follow-up, respectively. The reintervention-free survival was 62.2% at a 2-year follow-up.ConclusionsTreatment of femoropopliteal disease in CLTI patients with the use of the heparin-bonded Viabahn is safe and effective with favorable clinical outcomes and low amputation rates. Reinterventions are needed in a subset of the population to maintain endoprosthesis patency. Close follow-up using duplex is recommended to detect potential edge stenosis, allowing treatment before device occlusion.</p

    Breathe right nasal strips and the respiratory disturbance index in sleep related breathing disorders

    No full text
    This investigation assesses the effects of Breathe Right nasal strips on the respiratory disturbance index (RDI) measured by polysomnography in patients suffering from obstructive sleep apnea and snaring. The positive effect of these strips on nasal ventilation was shown in earlier studies. Twenty-six patients with art RDI higher than 10 in an initial measurement underwent a second preoperative polysomnography with Breathe Right nasal strips in place. Nineteen of these 26 patients showed reduction of RDI during the second night of polysomnography using the nasal strips, indicating that nasal obstruction seems to be a predominant factor in the etiology of snoring and apnea in these individuals. Demographic data, medical history, rhinoscopy, clinical assessment of pharyngeal obstruction (Mueller's maneuver), as well as anterior rhinomanometry and acoustic rhinometry were used to identify typical findings correlating with a positive effect of the Breathe Right nasal strips on the RDI: 1. Hyperplasia or hypertrophy of the lower turbinates, septal deviation, and/or allergic rhinitis. 2. None or only minor pharyngeal obstruction. 3. Age less than 55 years. if a positive effect is seen during polysomnography with the strips in place, patients will most likely profit from an improvement of nasal ventilation. This may help to target more effectively septal or turbinate surgery if applicable. In other cases, ifa significant RDI reduction is obtained by the use of the nasal strips, they could also offer a noninvasive modality of treatment, especially since the high degree of co-morbidity in this group of patients can sometimes make a surgical approach less favorable
    corecore